Suggested Topics within your search.
Suggested Topics within your search.
- Pharmacology 7
- Drugs 5
- Pharmaceutical Preparations 5
- methods 5
- Biochemistry 4
- Drug Therapy 4
- administration & dosage 4
- Nursing 3
- Chemistry, Clinical 2
- Chemotherapy 2
- Dosage 2
- Drug Dosage Calculations 2
- Health and Fitness 2
- Molecular biology 2
- Nursing Care 2
- Pharmaceutical arithmetic 2
- drug therapy 2
- nursing 2
- 17 drug summaries 1
- Anesthesia 1
- Anesthetics 1
- Biological Factors 1
- Cardiovascular Diseases 1
- Cardiovascular agents 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Computer programs 1
- Diabetes 1
- Diabetes Mellitus, Type 2 1
- Diseases 1
-
6621
Sicca Symptoms in Parkinson’s Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
Published 2020-01-01“…Overall, 75% of the subjects took at least one drug that can cause sicca symptoms (anti-PD medication, antidepressant drugs, antihypertensive drugs, antipsychotic drugs, antimuscarinic drugs, and analgesic drugs). …”
Get full text
Article -
6622
Diagnostic Performance between Histidine-Rich Protein 2 (HRP-2), a Rapid Malaria Diagnostic Test and Microscopic-Based Staining Techniques for Diagnosis of Malaria
Published 2020-01-01“…The patients included in the study did not receive any antimalarial drug. The mean age of the study participants was 31.6 ± 12.4 with the majority of participants being between 25 and 44 years and the minority being above 65 years. …”
Get full text
Article -
6623
Effect and safety of ethanolamine oleate in sclerotherapy in patients with difficult-to-resect venous malformations: A multicenter, single-arm study.
Published 2025-01-01“…Hemoglobinuria was observed in 23 patients (52%), a known drug-related adverse event. Prompt initiation of haptoglobin therapy led to full recovery within a month for these patients.…”
Get full text
Article -
6624
Potentiation of Doxorubicin Cytotoxicity Utilizing Clarithromycin Loaded-PEGylated Liposomes
Published 2025-01-01“…Background Doxorubicin (DOX) is a potent chemotherapeutic agent for breast cancer, but its effectiveness is often diminished by resistance mechanisms, particularly through p-glycoprotein (P-gp) mediated drug efflux. Clarithromycin (CAM), a macrolide antibiotic, inhibits multiple metabolic pathways including CYP3A and P-gp, potentially countering DOX resistance. …”
Get full text
Article -
6625
The Major Prognostic Features of Nuclear Receptor NR5A2 in Infiltrating Ductal Breast Carcinomas
Published 2015-01-01“…NR5A2 may be a potential drug target for treating a subset of breast cancer tumors across breast cancer subtypes, especially ER(−) breast tumors. …”
Get full text
Article -
6626
Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids
Published 2019-01-01“…This analysis indicates that physiological 3-D microenvironment may reshape the immunity of in vitro cortical spheroids and better recapitulate in vivo brain tissue function for disease modeling and drug screening.…”
Get full text
Article -
6627
Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella
Published 2025-02-01“…Collectively, our work opens new avenues toward the potentiation of COL and reveals an alternative drug combination strategy to overcome COL-resistant bacterial infections.…”
Get full text
Article -
6628
KaRhab: an international online registry for cardiac rhabdomyomas
Published 2025-01-01“…Conclusion In the view of the heterogeneity of treatment methods, a systematic overview of cardiac RHM is all the more important, especially as specific drug treatment options now exist. The registry should not just provide a comprehensive and informative overview of causes, time course, symptoms and therapeutic options of cardiac RHM but also facilitate information sharing among clinicians and researchers and serve as a basis for future clinical and pharmacological studies.…”
Get full text
Article -
6629
Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
Published 2025-01-01“…This study included 38 drug-naive patients with FES and 43 healthy controls (HCs). …”
Get full text
Article -
6630
-
6631
DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors
Published 2025-03-01“…These results have pointed out the use of DockCADD as an efficient tool for the fast and low-cost process of drug discovery; L1–L3 should be further validated experimentally for cancer therapy.…”
Get full text
Article -
6632
Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium
Published 2022-01-01“…The study aimed to investigate the long-term outcomes of a double stent scaffold strategy in patients with left main (LM) bifurcation lesions involving the ostium of the left circumflex artery (LCX), utilizing a drug-eluting stent (DES) in the LM extending into the left anterior descending artery (LAD) and a bioresorbable vascular scaffold (BVS) in the LCX ostium. …”
Get full text
Article -
6633
CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
Published 2025-02-01“…Furthermore, we constructed a co-expression network of CHST1 and explored its relationship with clinicopathological features, the tumor microenvironment, and immune infiltration through bioinformatics analysis. Finally, relevant drugs that inhibit CHST1 in GC were predicted using the drug susceptibility database (CellMiner) and Cancer Immunome Atlas. …”
Get full text
Article -
6634
Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Researc...
Published 2025-01-01“…It included adults newly diagnosed with inflammatory bowel disease and established on 5-aminosalicylic acid (5-ASA) treatment between 1 January 2007 and 31 December 2019. Drug discontinuation associated with 5-ASA nephrotoxicity defined as a prescription gap of ≥90 days with decline in kidney function was the outcome. …”
Get full text
Article -
6635
Biocompatible and Biodegradable Ultrafine Nanoparticles of Poly(Methyl Methacrylate-co-Methacrylic Acid) Prepared via Semicontinuous Heterophase Polymerization: Kinetics and Produc...
Published 2016-01-01“…Because of their biocompatibility and biodegradability as well as their extremely small size these nanoparticles could be used as vehicles for improved drug delivery in the treatment of chronic-degenerative diseases.…”
Get full text
Article -
6636
Tarred with the same brush: An initial inquiry into courtesy stigma and problem gambling
Published 2019-03-01“…Results: Problem gambling by a family member elicits more shame/embarrassment (M = 1.75) than using a wheelchair (M = 1.15) and having a mental illness (M = 1.22), but less shame than having a drug problem (M = 2.12) and on par with having an alcohol problem (M = 1.79, ns). …”
Get full text
Article -
6637
Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson’s Disease Is Not Associated with Increased Body Mass Index
Published 2017-01-01“…Subjects were randomized to DBS plus optimal drug therapy (DBS+ODT; n=15) or ODT (n=14) and followed for 24 months. …”
Get full text
Article -
6638
Luminescence enhancement of Y2O3:Er3+ and Y2O3:Yb3+/Er3+ sub-microcrystals by Zr4+ ions Co-doping
Published 2025-06-01“…This research contributes to the understanding of UC luminescent properties of lanthanide (Ln3+) ions doped UC materials and their technological applications in fields such as bioimaging, drug delivery, and optical temperature sensors.…”
Get full text
Article -
6639
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Published 2025-01-01“…PTMs associated with cancer can be exploited to better understand the underlying molecular mechanisms of this heterogeneous and chameleonic disease, find new biomarkers of cancer progression and prognosis, personalize oncotherapies, and discover new targets for drug development.…”
Get full text
Article -
6640
Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy
Published 2020-01-01“…The incidence of abnormal ECG increased from 43.75% at baseline to 65.63% at the end of chemotherapy, of which only the prevalence of fragmented QRS (fQRS) was significantly increased after the drug regimen (26.56% to 53.13%). At the end of the treatment, heart rate, P-wave dispersion, corrected QT interval, T-peak to T-end, RR, SV1, RV5, Sokolow–Lyon index (SLI), and index of cardioelectrophysiological balance deteriorated markedly (all P<0.05). …”
Get full text
Article